Screener
Rapid Micro Biosystems RPID Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -141.5%+10.7pp | -144.2%+15.4pp | -141.1%+36.9pp | -148.8%+49.5pp | -152.1%+67.6pp | |
| Net margin | -145.6%+0.1pp | -145.8%+5.4pp | -140.3%+26.9pp | -145.1%+39.8pp | -145.6%+58.6pp | |
| Returns | ||||||
| Return on equity | -141.6%-82.5pp | -116.7%-64.4pp | -86.8%-38.3pp | -68.8%-23.2pp | -59.2%-16.1pp | |
| Return on invested capital | -146.6%-59.3pp | -120.6%-54.2pp | -93.7%-33.3pp | -77.1%-19.3pp | -87.3%-27.7pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×+0.2× | 0.5×+0.2× | 0.4×+0.2× | 0.3×+0.1× | 0.3×+0.1× | |
| Liquidity | ||||||
| Current ratio | 2.5×-1.1× | 2.6×-2.0× | 3.3×-1.3× | 4.2×-1.3× | 3.7×-2.2× | |
| Leverage | ||||||
| Debt-to-equity | 1.3×+1.2× | 1.2×+1.1× | 0.7×+0.6× | 0.5×+0.5× | 0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $0.37-70.0% | $0.45-69.8% | $0.74-57.0% | $0.99-49.0% | $1.22-43.7% | |
| Valuation | ||||||
| Market capitalization | $83.77M-26.0% | $103.2M-9.6% | $128.54M+232% | $147.66M+287% | $148.15M+424% | |
| Price / sales | 2.4×-1.4× | 3×-0.8× | 3.8×+2.4× | 4.8×+3.4× | 4.9×+3.7× | |
| Price / book | 4.7×+2.6× | 5.1×+3.3× | 3.9×+3.4× | 3.3×+2.9× | 2.7×+2.4× |
FAQ
- What are Rapid Micro Biosystems's profit margins?
- Rapid Micro Biosystems (RPID) runs a 6.4% gross margin and a -141.5% operating margin, with a -145.6% net margin.
- Where do Rapid Micro Biosystems's ratios come from?
- Every ratio is computed from Rapid Micro Biosystems's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
